Please assess the completion status of the following clinical trial:

Trial Title: The Study for Evaluate of Satety and Dfficacy of Hemostatic Device

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* aged over 20 years~* Underwent coronary angiography under suspicion of coronary artery disease~* Agreed to participate in the trial before the coronary angiography procedure~Exclusion Criteria:~* Bleeding tendency due to congenital or acquired disorders such as severe liver disease, thrombocytopenia (platelet count below 50,000 cells/μL)~* Those who were on anticoagulants.~* Patients who could not provide voluntary consent.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 99 Years
- Healthy Volunteers: t

Study Arms:
- TRAcelet™ compression group (Type: EXPERIMENTAL): the group using TRAcelet™ received 2 hours and 15 minutes of compression from the device with 13 cc of air being blown in, followed by 3 stepwise releases every 15 minutes through counterclockwise rotation of the dial without extracting air using a syringe. This achieved the same 3 hours of compression. The dial started at the triangle position and was set to nine, six, and three at every stepwise decompression. After three hours, the device was released.
- Conventional compression group (Type: OTHER): Patients who were assigned to the conventional group received radial artery compression by a gauze pad folded into a cuboid shape, fastened with 3M™ Durapore™ surgical tape. The gauze pad was not impregnated with prothrombotic material. Compression was released at 3 hours to check for complications. An additional one hour of compression was applied when incomplete hemostasis or hematoma was identified.

Based on this trial design, predict the completion outcome and termination type (if applicable).